• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 12/19/14

    • 30-Day SEC Yield1

      1.88%
    • Total Net Assets

      $352.1M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.43%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      12/26/2014
  • Portfolio Composition (%)
    as of 12/19/14

    • % of Net Assets
    • Stocks

      100.03
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.03
  • Download All HoldingsAll Holdings (%)as of 12/19/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    351,848
    37,137,55610.55
    Novartis Ag
    NVS US
    360,373
    34,094,8889.68
    Pfizer Inc
    PFE US
    835,501
    26,685,9027.58
    Merck & Co Inc
    MRK US
    331,569
    19,754,8825.61
    Bristol-Myers Squibb Co
    BMY US
    296,041
    18,147,3145.15
    Abbvie Inc
    ABBV US
    264,412
    17,903,3365.09
    Actavis Plc
    ACT US
    63,980
    16,979,6524.82
    Eli Lilly & Co
    LLY US
    225,960
    16,359,5044.65
    Abbott Laboratories
    ABT US
    352,489
    16,232,1184.61
    Allergan Inc/United States
    AGN US
    76,226
    16,207,9344.60
    Novo Nordisk A/S
    NVO US
    365,656
    16,019,3894.55
    Sanofi
    SNY US
    337,624
    15,662,3774.45
    Glaxosmithkline Plc
    GSK US
    355,371
    15,405,3334.38
    Astrazeneca Plc
    AZN US
    202,432
    14,512,3504.12
    Teva Pharmaceutical Industries Ltd
    TEVA US
    228,657
    13,262,1063.77
    Valeant Pharmaceuticals International I
    VRX US
    79,812
    11,657,3413.31
    Shire Plc
    SHPG US
    52,060
    11,282,9643.20
    Mckesson Corp
    MCK US
    52,114
    11,002,3083.13
    Mylan Inc/Pa
    MYL US
    91,626
    5,269,4121.50
    Perrigo Co
    PRGO US
    30,874
    5,191,1551.47
    Zoetis Inc
    ZTS US
    117,062
    5,093,3681.45
    Mallinckrodt Plc
    MNK US
    26,878
    2,674,8990.76
    Hospira Inc
    HSP US
    35,565
    2,228,5030.63
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    30,164
    2,201,9720.63
    Salix Pharmaceuticals Ltd
    SLXP US
    10,339
    1,211,7310.34
    Other/Cash
    -113,992-0.03
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.